Pharmacovigilance system in Saudi Arabia

被引:34
作者
Alshammari, Thamir M. [1 ,2 ]
Alshakka, Mohammed [3 ]
Aljadhey, Hisham [2 ,4 ]
机构
[1] Univ Hail, Coll Pharm, POB 2457, Hail 11451, Saudi Arabia
[2] King Saud Univ, Medicat Safety Res Chair, Riyadh, Saudi Arabia
[3] Aden Univ, Coll Pharm, Aden, Yemen
[4] King Saud Univ, Coll Pharm, Riyadh, Saudi Arabia
关键词
ADRs; Drug safety; Healthcare system; Pharmacovigilance; Risk management plan; COMMUNITY PHARMACISTS KNOWLEDGE; CARE; SAFETY; FUTURE;
D O I
10.1016/j.jsps.2016.09.008
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pharmacovigilance plays an important role in ensuring that patients are receiving safe drugs. In Saudi Arabia, Saudi Food and Drug Authority, health institutions, marketing authorization holders and healthcare professional are involved in pharmacovigilance activities regardless of the level of the involvement. Although pharmacovigilance is well established in developed nations and it is considered a new concept in Saudi Arabia. It is a collective effort from various stakeholders to make pharmacovigilance successful toward promoting safe and effective use of medicines among the population. However, the practice of pharmacovigilance still needs more attention especially from marketing authorization holders and healthcare professionals. The aim of this review was to describe the current situation of pharmacovigilance in Saudi Arabia and the activities that have been conducted by the stakeholders. (C) 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
引用
收藏
页码:299 / 305
页数:7
相关论文
共 23 条
  • [1] Challenges to and the future of medication safety in Saudi Arabia: A qualitative study
    Aljadhey, Hisham
    Mahmoud, Mansour Adam
    Hassali, Mohamed Azmi
    Alrasheedy, Alian
    Alahmad, Amjad
    Saleem, Fahad
    Sheikh, Aziz
    Murray, Michael
    Bates, David W.
    [J]. SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (04) : 326 - 332
  • [2] Almalki M., 2011, Eastern Mediterranean Health Journal, V17, P784
  • [3] Alrwisan AA, 2014, SAUDI MED J, V35, P81
  • [4] [Anonymous], Pharmacovigilance
  • [5] Center Uppsala Monitoring, UPPS REP
  • [6] US Pharmacists' Effect as Team Members on Patient Care Systematic Review and Meta-Analyses
    Chisholm-Burns, Marie A.
    Lee, Jeannie Kim
    Spivey, Christina A.
    Slack, Marion
    Herrier, Richard N.
    Hall-Lipsy, Elizabeth
    Zivin, Joshua Graff
    Abraham, Ivo
    Palmer, John
    Martin, Jennifer R.
    Kramer, Sandra S.
    Wunz, Timothy
    [J]. MEDICAL CARE, 2010, 48 (10) : 923 - 933
  • [7] Davies Nicola, 2015, SUCCESSFUL PHARMACOV
  • [8] Improving Care Transitions: Current Practice and Future Opportunities for Pharmacists
    Hume, Anne L.
    Kirwin, Jennifer
    Bieber, Heather L.
    Couchenour, Rachel L.
    Hall, Deanne L.
    Kennedy, Amy K.
    LaPointe, Nancy M. Allen
    Burkhardt, Crystal D. O.
    Schilli, Kathleen
    Seaton, Terry
    Trujillo, Jennifer
    Wiggins, Barbara
    [J]. PHARMACOTHERAPY, 2012, 32 (11): : e326 - e337
  • [9] Pharmacovigilance Knowledge among Patients at a Teaching Hospital Lalitpur District, Nepal
    Jha, Nisha
    Rathore, Devendra S.
    Shankar, P. Ravi
    Gyawali, Sudesh
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (03) : 32 - 34
  • [10] Clinical pharmacists and inpatient medical care - A systematic review
    Kaboli, Peter J.
    Hoth, Angela B.
    McClimon, Brad J.
    Schnipper, Jeffrey L.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (09) : 955 - 964